Recruitment, selection effects and external validity in clinical trials

How to cite

Unfried, Kerstin; Priebe, Jan; Mbavu, Cédric. 2023. "Recruitment, selection effects and external validity in clinical trials." AEA RCT Registry. AEARCTR-0011276. https://doi.org/10.1257/rct.11276-1.1

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Kerstin Unfried* , Jan Priebe , Cédric Mbavu

* Primary investigator

Registry ID
AEARCTR-0011276
DOI
https://doi.org/10.1257/rct.11276-1.1
First registered
Last updated
Status
In development
Trial dates
2023-04-18 – 2026-12-31
Countries
Private
JEL codes
D91, I12
Registry record
http://www.socialscienceregistry.org/trials/11276

Abstract

There is a notable lack of knowledge on the external validity of clinical trials. The proposed study aims to fill this gap by providing insights into the magnitude and implications of selection effects into clinical trials. The objective of this study is to identify who participates in clinical trials with a particular focus on people’s socio-economic characteristics, abilities, personality traits, preferences, and behaviors by comparing the trial population to a general population (adults age 18 to 65). We will elaborate on potential biases in the estimation of treatment effects. Additionally, using an RCT compromising a control and two treatment groups the study will investigate to what extent the information provided in the clinical trial recruitment process influences the participation in the clinical trial of various population groups. The control group receives a standard recruitment campaign. Intervention groups will additionally receive an intervention aimed at encouraging persons to participate, whereby intervention T1 will aim to activate altruistic concerns and motives among respondents by emphasizing the positive benefits of clinical trial participation for the society and others (emphasizing altruism) and T2 aims at fostering trust and highlighting the rights of clinical trial participants to reduce anxiety and misperceptions. The study takes place as part of the LoaLoa cinical trials conducted by researchers of CERMEL in Lambaréné, Gabon.

Intervention

After a baseline survey, households will be randomly selected into control or treatment groups. There is one control group and two treatment groups (T1 & T2). The control group represents a standard outreach activity as typically implemented by the staff of the research institute CERMEL in order to recruit participants for their clinical trials. The treatment groups comprise alternative elements: T1 will focus on activating altruism related concerns in respondents by emphasizing the importance of diagnostic testing and clinical trials for society. T2 will address possible mistrust and anxiety. In T2 the intervention will strengthen trust and inform respondents about the rights of clinical trial participants. All three recruitment campaigns are expected to take around 10 minutes and will be done by CERMEL staff.

Experimental design

The experimental design involves an RCT in which randomization occurs at the household-level. The RCT involves one control condition and two additional treatment arms (T1, T2). The RCT will involve four stages: Stage 1: the baseline survey, stage 2: the interventions, stage 3: a post-intervention questionnaire and stage 4: Various real-world outcome measures spaced over time.

Design details

Randomization method
Randomization is done by the survey software and is programmed by the research team. The sample is not stratified since it involves a complete census of the respective adult population (age 18-65)
Randomization unit
Randomization of interventions are at the household level.
Clusters
around 900 households
Observations
We have 3 conditions (1 control and 2 treatment arms) and assume minimum detectable effect size (MDE) of about 8 to 10 pp. Calculations show that the study will have sufficient statistical power if we recruit a minimum of 2,000 persons (about 670 persons per treatment arm). Out of these 2,000 persons a sub-sample will be potential clinical trial participants.
Arms
We aim to have about 670 persons per treatment arm. Randomization is done at the household level. We expect that per household on average 2 persons take part in the survey, resulting in around 335 clusters per treatment arm.
Primary outcomes
Our principal outcome variables (left-hand side variables) are as follows: • Willingness to participate in LoaLoa pre-screening • Willingness to participate in LoaLoa clinical trial • Participation in LoaLoa pre-screening • Conditional on being LoaLoa positive: Participation in various steps of the clinical trial
Secondary outcomes
Secondary outcomes include variables that we will use to investigate mechanisms through heterogeneous treatment effects. Secondary outcomes are related to (a) trust (b) altruism and pro-social preferences (c) individual health status (d) perceptions and attitudes toward clinical trials and Loa loa, (e) social norms, and (f) coping capacity of participants.

Cited by

No citation data available for this registration yet.

Keywords